Unihealth Hospitals Ltd

- The company plans a capital investment of INR 50-75 crores this year for expansion in Nasik and East Africa, adding around 300 beds. - Funding sources include internal accruals, proceeds from warrants issued amounting to INR 10.5 crores, and exploring banking facilities in India for equipment finance and working capital. - Promoters are willing to continue infusing funds as they did earlier this year via warrant issues. - The company is open to raising additional capital from existing investors and the public if needed for expansion. - Debt is expected to be used prudently, with a target debt-to-equity ratio not exceeding 1 for new projects to ensure financial closure. - The Ugandan subsidiary is expected to become debt-free soon, improving the overall debt position for future fundraising capacity.

- Planned capital investment of INR 50 to 75 crores for this year to add around 300 beds in Nasik and East Africa. - Capex mainly funded through internal accruals and part from INR 10.5 crores raised via warrant issue. - Exploring banking facilities in India for equipment finance and working capital limits. - Expansion includes adding beds in Mumbai (60 beds currently), Nasik (190 beds), and potential Pune project under discussion for next financial year. - Open to raising additional capital through promoters infusing funds, preferential allotment, public fundraise, and possible debt, depending on requirements. - Considering acquiring remaining 50% stake in UniHealth Victoria Hospital (Uganda), with estimated outlay of about US$10 million, subject to due diligence and strategic decision. - Expansion strategy balances Brownfield (acquisition) and Greenfield (new project) approaches.

- Expansion underway to add 250 beds in India (Mumbai and Nasik) and 100-150 beds in East Africa this year, aiming for 300-400 new beds in total. - Target to cross 1,000 beds across India and Africa within the next 3 years. - India’s contribution to consolidated revenue expected to rise to about 30%-35% over next 1-2 years as new Indian facilities become operational. - Uganda remains a mature, significant revenue contributor, but will form less than one-third of consolidated revenue in future. - Revenue realization anticipated to increase in next 2 years aligned with project cycles and commissioning of new facilities, such as Navi Mumbai in July. - Consultancy business expected to grow but hospital and medical centers will remain primary growth drivers. - Capital expenditure around INR 50-75 crores planned this year to support capacity expansion, funded through internal accruals, warrants, and banking facilities. - Strategic focus on clinical excellence, operational sustainability, and regionally relevant healthcare services for meaningful capacity growth.

- FY '25 showed strong growth: consolidated income up 16%, EBITDA at INR 21.32 crores, net profit up nearly 47% to INR 15.14 crores. - EPS rose from INR 7.67 in FY '24 to INR 9.83 in FY '25, demonstrating operating leverage and cost discipline. - Consultancy margins are high (50-60%), hospital business EBITDA margins steady at 30-35%. - Growth projections focus mainly on hospitals/medical centers, with uncertain scaling in consultancy revenue. - Expansion underway in India and East Africa: anticipating addition of 250-400 beds this year, targeting 1000+ beds in 3 years. - Capital expenditure of INR 50-75 crores planned for adding ~300 beds in Nasik and East Africa funded largely from internal accruals and warrants. - Promoters open to further capital infusion through warrants or investors to fund expansion. - Revenue realization expected to increase over next 2 years with commissioned projects ramping up. - Overall, earnings and profitability expected to improve aligned with capacity expansion and operational efficiencies.

The provided pages of the transcript do not explicitly mention the current or expected order book or pending orders for UniHealth Hospitals Limited. The discussion primarily focuses on: - Expansion plans, including bed capacity increases in India (Mumbai, Nasik, Pune) and East Africa. - Capital expenditure plans for capacity expansion (INR 50 to 75 crores for about 300 beds). - Funding sources including internal accruals, warrants (INR 10.5 crores), and banking facilities. - Strategy combining Greenfield and Brownfield projects. - Operational bed count and future targets (crossing 1,000 beds in 3 years). - Market positioning and competitive advantages. No specific details about order books or pending orders are provided in the accessible text. If more precise information is required, kindly provide relevant pages for review.